I n 2011, Choi et al 1 identified mutations in the Kir 3.4 (KCNJ5) K + channel in about one third of 24 aldosteroneproducing adenoma (APA), which were shown to lead to a loss of selectivity for Na + and thus to Ca 2+ influx, via opening of T-type calcium channel and activation of the Na + /Ca 2+ exchange, 2,3 and thus increased aldosterone production. Of note, these mutations were found to involve from 30% to 70% of all APA in a very large meta-analysis, albeit with marked geographic variations. 4 Some macrolide antibiotics and their derivatives were recently shown to correct the altered electrophysiology of HEK293T cells transfected with the L168R and G151R KCNJ5 mutated Kir 3.4 channel and to concentration dependently lower aldosterone synthesis in HAC15, an adrenocortical carcinoma cell line transfected to overexpress these mutated channels.
I
n 2011, Choi et al 1 identified mutations in the Kir 3.4 (KCNJ5) K + channel in about one third of 24 aldosteroneproducing adenoma (APA), which were shown to lead to a loss of selectivity for Na + and thus to Ca 2+ influx, via opening of T-type calcium channel and activation of the Na + /Ca 2+ exchange, 2, 3 and thus increased aldosterone production. Of note, these mutations were found to involve from 30% to 70% of all APA in a very large meta-analysis, albeit with marked geographic variations. 4 Some macrolide antibiotics and their derivatives were recently shown to correct the altered electrophysiology of HEK293T cells transfected with the L168R and G151R KCNJ5 mutated Kir 3.4 channel and to concentration dependently lower aldosterone synthesis in HAC15, an adrenocortical carcinoma cell line transfected to overexpress these mutated channels. 5 Notably, these effects were suggested to be specific in that they were not seen in the same cells carrying the wild-type Kir 3.4 channel. 5 These seminal discoveries might open the way to personalized diagnosis and treatment of primary aldosteronism, the most common, albeit often overlooked, form of secondary arterial hypertension, 6 which carries an excess cardiovascular damage, as well as a worse outcome. 7, 8 In fact, if these in vitro findings could be confirmed in vivo, the fall of plasma aldosterone concentration after administration of a macrolide antibiotic might represent a proxy for the presence of an APA carrying a KCNJ5 mutation. Likewise, if associated with a blood pressure lowering, this plasma aldosterone concentration fall would suggest the feasibility of controlling the aldosteronism and arterial hypertension with a macrolide or derivatives devoid of antibiotic activity. As APAs are known to be highly heterogeneous at the molecular level 9 and therefore could respond differently to stimuli and drugs, a first inevitable step toward these clinical applications is to prove that the effects seen in these 2 models of genetically engineered cell lines, which are far from APA cells, do occur also in the APA cells taken ex vivo from APA patients. Therefore, by taking advantage of the availability of primary culture of aldosterone-producing cells isolated ex vivo from wild-type APA and from G151R and L168R mutated APA, we conducted a pilot study to test the effect on aldosterone synthase (CYP11B2) gene expression and aldosterone production of clarithromycin, one of the macrolides that effectively corrected the altered electrophysiology of G151R and L168R overexpressing HEK293T cells. Abstract-Aldosterone-producing adenoma (APA), a major subtype of primary hyperaldosteronism, the main curable cause of human endocrine hypertension, involves somatic mutations in the potassium channel Kir3.4 (KCNJ5) in 30% to 70% of cases, typically the more florid phenotypes. Because KCNJ5 mutated channels were reported to be specifically sensitive to inhibition by macrolide antibiotics, which concentration dependently blunts aldosterone production in HAC15 transfected with the G151R and L168R mutated channel, we herein tested the effect of clarithromycin on aldosterone synthesis and secretion in a pure population of aldosterone-secreting cells obtained by immunoseparation (CD56 + cells) from APA tissues with/without the 2 most common KCNJ5 mutations. From a large cohort of patients with an unambiguous APA diagnosis, we recruited those who were wild type (n=3) or had G151R (n=2) and L168R (n=2) mutations. We found that clarithromycin concentration dependently lowered CYP11B2 gene expression (by 60%) and aldosterone secretion (by 70%; P<0.001 for both) in CD56 + cells isolated ex vivo from KCNJ5 mutated APAs, although it was ineffective in CD56 + cells from wild-type APAs. By proving the principle that the oversecretion of aldosterone can be specifically blunted in APA cells ex vivo with G151R and L168R mutations, these results provide compelling evidence of the possibility of specifically correcting aldosterone excess in patients with APA carrying the 2 most common KCNJ5 somatic mutations. 
Methods

Patients
From a large databank of cells from APA patients, we selected for this study a total of 7 patients. These patients received an unambiguous diagnosis of APA by the 4 corners criteria. 6 Approval for this study was obtained from the Ethics Committee of the University of Padova, and all participants gave informed written consent to the study and to the use of their adrenocortical specimen; all procedures followed the Helsinki Declaration Principles.
Detection of KCNJ5 Mutations
DNA was extracted from APAs removed from the consecutive APA patients referred to our specialized hypertension center with a standard procedure as reported. 10 PCR was performed on 250 ng DNA in a final volume of 50 µL containing 300 nmol/L MgCl 2 , 400 nmol/L of each primer, 200 µmol/L deoxynucleotide triphosphate, and 2.6 U expand high-fidelity enzyme mix (Roche Applied Science, Milan, Italy). Purified PCR products underwent direct Sanger sequencing using the ABI Prism Big Dye Terminator version 3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA) on an ABI Prism 3700 DNA analyzer (Applied Biosystems).
Isolation of Aldosterone-Producing Cells
Dispersed APA cells were obtained by sequential enzymatic digestion, mechanical disaggregation, and incubation in 5 mL of Krebs Ringer solution supplemented with 2 mg/mL collagenase-I, 0.1 mg/ mL deoxyribonuclease-I, 4% bovine serum albumin at 37°C for 40 minutes with gentle shaking. Single-cell suspension obtained was washed with phosphate buffer salt containing 0.1% bovine serum albumin and then incubated with CD56 precoated magnetic beads by gentle shaking for 1 hour at 4°C. Beads were used at a ratio of 5 beads per cell. 11 After separating the bead-bound CD56-positive (CD56 + ) cells with a magnet, the CD56 + cells were seeded at a density of 10 4 cells/cm 2 into 24-well plates and treated with 5, 20, or 50 μmol/L of clarithromycin.
Electron Microscopy
Freshly immunoseparated CD56 + APA cells were fixed in 3% phosphate-buffered glutaraldehyde and processed following a standard protocol, as described.
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CYP11B2 Gene Expression Quantification
CYP11B2 mRNAs were measured in duplicate in CD56 + APA cells after incubation for 18 hours in DMEM-F-12 medium with 5% FBS added with increasing concentrations of clarithromycin.
After treatment, the cells were lysed and mRNA was isolated using the high-pure RNA isolation kit (Roche Applied Science). Gene expression was quantified by real-time RT-PCR with universal probe library probes in the LightCycler 480 instrument (Roche Applied Science) using the comparative cycle threshold (2 −ΔΔCt ) method and the porphobilinogen deaminase as reference gene.
Aldosterone Measurement
Aldosterone levels were quantified by an aldosterone ELISA kit (Alpha Diagnostic International, San Antonio, TX). A total of 50 μL of cell medium was added to aldosterone-coated wells following the manufacturer's instructions; the signal was detected in an ELISA Reader (Berthold Technologies, Milan, Italy). Aldosterone levels were normalized to the amount of cell RNA content.
Statistical Analysis
Data are expressed as mean and SD. One-way ANOVA followed by Bonferroni post hoc test and repeated-measure ANOVA were used to test the effect of clarithromycin and its increasing concentration among APA groups. The nonparametric Mann-Whitney test was used to compare CD56 + and CD56 − cells for quantitative variables. Significance was set at P <0.05. The GraphPad for Mac (vers. 6.0 GraphPad Software, Inc, San Diego, CA) and SPSS (version 24 for Mac, IBM) softwares were used for statistical analysis.
Results
Characteristics of the APA Patients
We selected 7 primary aldosteronism (PA) patients, who were unambiguously diagnosed with APA by the 4 corners criteria 6 : of them 3 were found to be wild type, 2 had G151R, and 2 had L168R mutations at sequencing. All showed the florid PA phenotype expected in APA patients, with no clear-cut differences among genotypes from the clinical standpoint (Table) . By definition all were biochemically cured of PA and became normotensive without treatment after unilateral adrenalectomy. Figure 1A, n=7 ). Electron microscopy demonstrated that dispersed CD56 + APA cells were selectively bound to CD56-precoated beads. These cells showed the classical features of steroidogenic aldosterone-producing APA cells, 13 for example, abundant mitochondria with tubule-vesicular cristae, abundant lipid droplets, some liposomes, and smooth endoplasmic reticulum profiles ( Figure 1B) .
Effect of Clarithromycin on CYP11B2 Gene Expression and Aldosterone Release
Compared with the CD56 + cells isolated from the wild-type APA, the G151R and L168R mutated APA showed a significantly higher in vitro production of aldosterone ( Figure 2B and 2D). When CD56 + cells isolated from G151R mutated (Figure 2A , circle symbols) and L168R APAs (Figure 2A , square symbols) were exposed to increasing concentrations (5-50 μmol/L) of clarithromycin, we found a consistent concentration-dependent blunting effect of clarithromycin on both CYP11B2 gene expression (Figure 2A ) and aldosterone release ( Figure 2B ), which did not occur in wild-type APA cells (Figure 2A and 2B, triangle symbol). No differences in CYP11B2 gene expression changes and the aldosterone production lowering between the G151R and the L168R mutated APA cells were seen at post hoc Bonferroni test. Therefore, the results obtained in the mutated APA cells were examined jointly and compared with the wild-type APA cells ( Figure 2C  and 2D ). This showed a highly significant (P<0.001) effect of clarithromycin concentration and group at repeated-measures ANOVA.
Discussion
In this proof-of-principle study, we selected 7 patients, who were unambiguously diagnosed with APA by the 4 corners criteria, as confirmed by biochemical cure of PA and normotension without treatment after unilateral adrenalectomy. 6 They showed the florid PA phenotype expected in APA patients, but no clear-cut differences among genotypes from the clinical standpoint. Of them, 3 were found to be wild type, 2 had G151R, and 2 had L168R mutations at sequencing. The APA tissue obtained at adrenalectomy was used to obtain dispersed APA cells from which a pure population of aldosterone-secreting cells could be immunoseparated using CD56 precoated magnetic beads, as described in detail.
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When exposed to increasing concentrations of clarithromycin, the CD56 + cells obtained from wild-type APAs showed no change of CYP11B2 gene expression and aldosterone secretion in response to the macrolide (Figure 2 ). By contrast, both G151R or L168R APA cells exposed to clarithromycin showed a concentration-dependent consistent blunted expression of the aldosterone synthase gene (CYP11B2), the step-limiting enzyme, which in a 3-step process converts deoxycorticosterone to aldosterone in the mitochondria. Moreover, both G151R and L168R mutated CD56 + APA cells, which exhibited a higher in vitro production of aldosterone than wild-type APA cells at baseline in keeping with the literature, 4,14 showed a concentrationdependent consistent brisk fall also of aldosterone release ( Figure 2B and 2D) . Therefore, these experiments extend the finding obtained in vitro in the HAC15 cell line engineered to overexpress the mutated G151R and L168R Kir3.4 channel, 5 to APA cells obtained ex vivo, which had these 2 common somatic mutations.
Perspectives
These results, albeit obtained in a small data set, provide compelling evidence of the feasibility of blunting aldosterone synthesis specifically in aldosterone-producing cells from tumors carrying 2 most common KCNJ5 mutations.
Whether these effects occur in all KCNJ5 mutated APA cells and whether they can happen in vivo in patients with KCNJ5 mutated APA, and whether the lowering of plasma aldosterone concentration and blood pressure after acute administration of a macrolide can be a proxy for + cells isolated from G151R mutated (circle symbols, n=2) and L168R APAs (square symbols, n=2) but not in those wildtype APAs (triangle symbols, n=3). Each experiment was performed in duplicate: please note the consistency of the findings. Aldosterone production was significantly higher at baseline in the KCNJ5 mutated than in wild-type APA (*P<0.01). Given the similar response to clarithromycin of G151R and L168R APA cells, the downstream analysis was performed by cumulating these 4 APA together (C and D). At repeatedmeasures ANOVA, there was a highly significant (P<0.001) lowering of both CYP11B2 mRNA and aldosterone production in the mutated group and a highly significant (P<0.001) difference of the change when compared with wildtype APA cells. 0 denotes exposure to vehicle. Data represent mean±SD.
